These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 12409596)
1. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Riemann B; Papke K; Hoess N; Kuwert T; Weckesser M; Matheja P; Wassmann H; Heindel W; Schober O Radiology; 2002 Nov; 225(2):567-74. PubMed ID: 12409596 [TBL] [Abstract][Full Text] [Related]
2. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas. Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918 [TBL] [Abstract][Full Text] [Related]
3. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas. Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348 [TBL] [Abstract][Full Text] [Related]
5. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose. Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas. Skogen K; Schulz A; Dormagen JB; Ganeshan B; Helseth E; Server A Eur J Radiol; 2016 Apr; 85(4):824-9. PubMed ID: 26971430 [TBL] [Abstract][Full Text] [Related]
11. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790 [TBL] [Abstract][Full Text] [Related]
12. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193 [TBL] [Abstract][Full Text] [Related]
13. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672 [TBL] [Abstract][Full Text] [Related]
14. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas. Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600 [TBL] [Abstract][Full Text] [Related]
15. Effect of age and tumor grade on BOLD functional MR imaging in preoperative assessment of patients with glioma. Chen CM; Hou BL; Holodny AI Radiology; 2008 Sep; 248(3):971-8. PubMed ID: 18647847 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT]. Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287 [TBL] [Abstract][Full Text] [Related]
19. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions. Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143 [TBL] [Abstract][Full Text] [Related]